Skip to content

Development of a distress management application for cancer survivors on cancer journey

Development of Distress Management System and Non pharmacological Interventions in Cancer Survivors

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CRIS
Registry ID
KCT0010890
Enrollment
114
Registered
2025-08-12
Start date
2025-04-24
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Others(Cancer survivor distress self-management mobile application) : 1) Conducting psychoeducation on the list of distress problems (physical, psychological symptoms, life problems, interpersonal rel

Sponsors

National Cancer Center
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Must meet all of the following conditions: clinical trials 1. Diagnosed with breast, stomach, or pancreatic cancer, aged 20-65 years, and stage 0-3 2. In distress (distress thermometer score of 1 or more) 3. Able to use the Android mobile app 4. Agree to participate in this study and willingly sign a written informed consent form 5. Undergoing cancer treatment or within 5 years of completing active cancer treatment qualitative research 1. Participated in a clinical trial and wish to be interviewed

Exclusion criteria

Exclusion criteria: One or more of the following Clinical trials 1. Stomach or breast cancer patients who receiving or scheduled to receive chemSmartphonering the study 2. Smartphone users who are unable to install the app 3. Individuals deemed by the researcher to be at risk of suicide, self-harm, or homicide 4. Patients whose requires physical condition need to acute care 5. Individuals with limited communication due to visual, auditory, or cognitive impairment Any of the following conditions: Qualitative research 1. If you did not agree to be interviewed 2. If you did not voluntarily sign the consent form

Design outcomes

Primary

MeasureTime frame
distress (Distress Thermometer);Distress scores, including depression (PHQ-9);Distress scores, including anxiety (GAD-7);Distress scores, including NCC-PSI (depression, anxiety, insomnia);Distress scores, including Insomnia Severity Inventory (ISI)

Secondary

MeasureTime frame
Recruitment;Retention;Compliance rate;Quality of life (EQ-5D, EORTC-QLQ-CL30);Cancer adjustment (Mini-MAC);Self-efficacy (CS-SES);Digital Phenotypes: heart rate variability (HRV);Digital Phenotypes: activity (steps per week, total steps per day, distance covered);Digital Phenotypes: sleep pattern (total sleep time, sleep onset/end time, app usage information including sleep duration by stage (awake, light, REM, deep), daily activity time);Number of app uses, app usage time, and completion rate per session;Call/ text count;User experience (UX) and app satisfaction;Interview content (demographics (participant unique serial number, age, occupation, gender), relaxation, digital health experience, health interest, information quality, enjoyment, and self-efficacy);Eastern Cooperative Oncology Group (ECOG)

Countries

Korea, Republic of

Contacts

Public ContactSe Jeong Cha

National Cancer Center

cs0810cs@ncc.re.kr+82-31-920-2959

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026